US Food and Drug Administration review divisions are not being pushed to require advisory committee votes or only discussions, just to ensure that staff obtain the input they need to decide on pending applications.
As part of advisory committee reform efforts, FDA officials have been writing internal documents outlining best practices for determining when...
Welcome to HBW Insight
Create an account to read this article
Already a subscriber?